GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Arco Resources Corp (FRA:MJ72) » Definitions » Debt-to-EBITDA

Arco Resources (FRA:MJ72) Debt-to-EBITDA : -3.29 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Arco Resources Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Arco Resources's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €25.80 Mil. Arco Resources's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €150.83 Mil. Arco Resources's annualized EBITDA for the quarter that ended in Mar. 2024 was €-53.74 Mil. Arco Resources's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was -3.29.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Arco Resources's Debt-to-EBITDA or its related term are showing as below:

FRA:MJ72' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -41.7   Med: -4.09   Max: 31.87
Current: -5.15

During the past 13 years, the highest Debt-to-EBITDA Ratio of Arco Resources was 31.87. The lowest was -41.70. And the median was -4.09.

FRA:MJ72's Debt-to-EBITDA is ranked worse than
100% of 656 companies
in the Drug Manufacturers industry
Industry Median: 1.715 vs FRA:MJ72: -5.15

Arco Resources Debt-to-EBITDA Historical Data

The historical data trend for Arco Resources's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arco Resources Debt-to-EBITDA Chart

Arco Resources Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.31 -5.85 -41.70 31.87 -11.49

Arco Resources Quarterly Data
Apr19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -280.73 -19.19 -1.96 7.83 -3.29

Competitive Comparison of Arco Resources's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Arco Resources's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arco Resources's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Arco Resources's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Arco Resources's Debt-to-EBITDA falls into.



Arco Resources Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Arco Resources's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(25.08 + 167.342) / -16.745
=-11.49

Arco Resources's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(25.8 + 150.834) / -53.736
=-3.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Arco Resources  (FRA:MJ72) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Arco Resources Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Arco Resources's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Arco Resources (FRA:MJ72) Business Description

Traded in Other Exchanges
Address
5060 North 40th Street, Suite 120, Phoenix, AZ, USA, 85018
4Front Ventures Corp is a Canadian-based company. It is engaged in the cultivation, processing, extracting, manufacturing, and distribution of cannabis products. It operates in two segments: THC Cannabis and CBD Wellness. The THC Cannabis segment engages in the production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to own dispensaries and third-party retail customers. The CBD Wellness segment encompasses the production and sale of CBD products to third-party customers.

Arco Resources (FRA:MJ72) Headlines

No Headlines